ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,473,000 | +88.7% | 398,728 | -0.7% | 0.02% | +88.9% |
| Q1 2019 | $9,792,000 | +100.2% | 401,649 | +17.0% | 0.01% | +80.0% |
| Q4 2018 | $4,892,000 | -7.5% | 343,274 | -1.4% | 0.01% | 0.0% |
| Q3 2018 | $5,290,000 | -12.4% | 348,001 | -3.4% | 0.01% | -16.7% |
| Q2 2018 | $6,042,000 | +3.0% | 360,067 | +0.2% | 0.01% | 0.0% |
| Q1 2018 | $5,864,000 | +26.5% | 359,263 | -0.8% | 0.01% | +50.0% |
| Q4 2017 | $4,635,000 | -15.3% | 362,132 | -18.6% | 0.00% | -20.0% |
| Q3 2017 | $5,473,000 | +45.2% | 444,967 | -1.2% | 0.01% | +25.0% |
| Q2 2017 | $3,768,000 | -4.3% | 450,202 | +2.2% | 0.00% | -20.0% |
| Q1 2017 | $3,938,000 | -21.4% | 440,408 | -22.7% | 0.01% | -16.7% |
| Q4 2016 | $5,007,000 | +35.8% | 569,684 | +4.3% | 0.01% | +20.0% |
| Q3 2016 | $3,687,000 | +104.7% | 546,147 | +7.9% | 0.01% | +66.7% |
| Q2 2016 | $1,801,000 | +18.7% | 506,024 | -1.5% | 0.00% | +50.0% |
| Q1 2016 | $1,517,000 | -30.4% | 513,972 | -0.4% | 0.00% | -33.3% |
| Q4 2015 | $2,179,000 | -7.4% | 516,260 | -0.0% | 0.00% | -25.0% |
| Q3 2015 | $2,354,000 | -35.8% | 516,274 | +1.6% | 0.00% | -20.0% |
| Q2 2015 | $3,664,000 | +7.8% | 508,035 | +10.2% | 0.01% | 0.0% |
| Q1 2015 | $3,398,000 | +17.7% | 461,054 | -24.4% | 0.01% | +25.0% |
| Q4 2014 | $2,887,000 | +32.9% | 610,177 | +0.3% | 0.00% | 0.0% |
| Q3 2014 | $2,173,000 | -40.7% | 608,467 | -24.3% | 0.00% | -33.3% |
| Q2 2014 | $3,665,000 | -1.1% | 803,717 | +1.9% | 0.01% | -14.3% |
| Q1 2014 | $3,707,000 | -13.3% | 788,680 | -7.6% | 0.01% | -12.5% |
| Q4 2013 | $4,276,000 | -50.0% | 853,611 | -37.9% | 0.01% | -55.6% |
| Q3 2013 | $8,551,000 | +34.2% | 1,374,719 | -2.0% | 0.02% | +28.6% |
| Q2 2013 | $6,370,000 | – | 1,403,004 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |